We are live on ! Find out more
BA

Boston Advisors Portfolio holdings

AUM $1.91B
1-Year Est. Return 6.26%
This Fund
S&P 500
This Quarter Est. Return
+0.93%
1 Year Est. Return
+6.26%
3 Year Est. Return
+73.82%
5 Year Est. Return
+112.87%
10 Year Est. Return
AUM
$4.06B
AUM Growth
-$216M
Cap. Flow
-$186M
Cap. Flow %
-4.57%
Top 10 Hldgs %
19.83%
Holding
736
New
89
Increased
195
Reduced
242
Closed
87

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$35.7M
2
JNJ icon
Johnson & Johnson
JNJ
+$26.2M
3
LLL
L3 Technologies, Inc.
LLL
+$25M
4
CLX icon
Clorox
CLX
+$21.2M
5
V icon
Visa
V
+$21M

Top Sells

Rank Stock Value
1
MA icon
Mastercard
MA
+$47.9M
2
AMZN icon
Amazon
AMZN
+$31M
3
AGN
Allergan plc
AGN
+$26.5M
4
CTSH icon
Cognizant
CTSH
+$22.3M
5
UAL icon
United Airlines
UAL
+$20.1M

Sector Composition

Rank Sector Weight
1 Healthcare 17.26%
2 Technology 13.82%
3 Financials 10.83%
4 Communication Services 10.67%
5 Consumer Staples 9.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STZ icon
451
Constellation Brands
STZ
$22.2B
$425K 0.01%
2,812
-100
-3% -$14.4K
CPHD
452
DELISTED
Cepheid Inc
CPHD
$423K 0.01%
+12,690
New +$398K
OMCL icon
453
Omnicell
OMCL
$1.86B
$419K 0.01%
15,045
+90
+0.6% +$2.47K
PCY icon
454
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.38B
$419K 0.01%
14,790
+4,125
+39% +$113K
EFAV icon
455
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.22B
$417K 0.01%
6,270
-10,865
-63% -$691K
VE
456
DELISTED
VEOLIA ENVIRONNEMENT
VE
$416K 0.01%
17,249
AVB icon
457
AvalonBay Communities
AVB
$27.1B
$415K 0.01%
+2,180
New +$385K
IWO icon
458
iShares Russell 2000 Growth ETF
IWO
$14.5B
$414K 0.01%
3,121
NICE icon
459
Nice
NICE
$5.29B
$413K 0.01%
6,369
HRC
460
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$413K 0.01%
+8,215
New +$388K
DTE icon
461
DTE Energy
DTE
$31.1B
$411K 0.01%
5,324
HPQ icon
462
HP
HPQ
$23.5B
$410K 0.01%
33,289
-3,200
-9% -$34.2K
PCAR icon
463
PACCAR
PCAR
$69.6B
$402K 0.01%
11,033
+645
+6% +$21.6K
WR
464
DELISTED
Westar Energy Inc
WR
$402K 0.01%
8,100
WCN
465
Waste Connections
WCN
$42.8B
$395K 0.01%
9,170
TAP icon
466
Molson Coors Class B
TAP
$7.68B
$392K 0.01%
4,078
+845
+26% +$75.4K
BSCK
467
DELISTED
Invesco BulletShares 2020 Corporate Bond ETF
BSCK
$390K 0.01%
18,223
+7,270
+66% +$153K
IEF icon
468
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
$382K 0.01%
3,460
-2,040
-37% -$222K
IFX
469
DELISTED
INFINEON TECH AG ADS(REP1 ORD)
IFX
$379K 0.01%
26,614
UFS
470
DELISTED
DOMTAR CORPORATION (New)
UFS
$379K 0.01%
9,365
-150
-2% -$5.13K
VA
471
DELISTED
Virgin America Inc.
VA
$376K 0.01%
9,760
+60
+0.6% +$1.87K
PRMW
472
DELISTED
Primo Water Corporation
PRMW
$375K 0.01%
+27,025
New +$307K
IPXL
473
DELISTED
Impax Laboratories, Inc.
IPXL
$373K 0.01%
11,660
EMC
474
DELISTED
EMC CORPORATION
EMC
$370K 0.01%
13,902
-5,000
-26% -$127K
TRV icon
475
Travelers Companies
TRV
$80.8B
$367K 0.01%
3,143
-15
-0.5% -$1.64K

Similar funds

Boston Advisors's Q1 2016 Portfolio in Review

As of Q1 2016, Boston Advisors held 736 positions worth $4.06B, down 5.1% from $4.28B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Boston Advisors withdrew a net $186M in Q1 2016, closing 87 positions and reducing 242 holdings. Its most notable exit was DYAX CORPORATION, an estimated $16.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Technology and Financials.

Against the trend, Boston Advisors opened a new position in Baxter International worth $16.4M.

  • Boston Advisors's largest Q1 2016 buy was Baxter International: 399,091 shares worth $16.4M.
  • Boston Advisors added most to AbbVie in Q1 2016, an estimated $35.7M increase.
  • Boston Advisors's biggest Q1 2016 reduction was Mastercard, cutting an estimated $47.9M.
  • Boston Advisors fully exited DYAX CORPORATION in Q1 2016, selling an estimated $16.2M.
  • Boston Advisors's ten largest holdings make up 20% of its $4.06B portfolio in Q1 2016.
  • Boston Advisors opened 89 new positions and closed 87 in Q1 2016.
  • Boston Advisors's portfolio value fell 5.1% quarter-over-quarter to $4.06B.

Based on Boston Advisors's 13F filing for Q1 2016, filed 20 Apr 2016.